Basking Biosciences
Pre-clinicalAdvancing reversible therapies targeting von Willebrand Factor for safer treatment of acute thrombotic conditions. Precision control when seconds matter.
Founded
2019
Focus
RNA & Gene Therapy
About
Advancing reversible therapies targeting von Willebrand Factor for safer treatment of acute thrombotic conditions. Precision control when seconds matter.
Funding History
2Total raised: $58.5M
Series A$55MARCH Venture PartnersFeb 15, 2023
Seed$3.5MRev1 VenturesOct 15, 2020
Company Info
TypePrivate
Founded2019
LocationColumbus, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile